96 Tests PN: A111134
32 Tests PN: A111134T
45x Ab-conjugated beads (S4P10 - human IL-11 Ab-bead).
96 Tests PN: A111134A. One vial containing 100 µL of anti-human IL-11 conjugated to AimPlex Bead S4P10.
32 Tests PN: A111134TA. One vial containing 100 µL of anti-human IL-11 conjugated to AimPlex Bead S4P10.
25x Biotin-detection Ab (human IL-11 Biotin-dAb).
96 Tests PN: A111134B. One vial containing 100 µL of biotinylated anti-human IL-11.
32 Tests PN: A111134TB. One vial containing 100 µL of biotinylated anti-human IL-11.
Lyophilized Standard Mix-Human Group 2 Panel A, 10-Plex.
96 & 32 Tests PN: HG2009A. One vial containing lyophilized recombinant human G-CSF, GM-CSF, IFNα2, IL-1α, IL-3, IL-5, IL-7, IL-11, IL-12p40, and IL-13. Note: If multiple analyte kits on the above target list are ordered as a panel, only one vial of standard mix is supplied for those analyte kits.
Application: Optimal antibody pair and antigen standard for assaying human IL-11. Can be multiplexed with other analytes in Human Group 2. To be used in conjunction with the AimPlex NR Basic Kit (96 Tests PN: P100001, 32 Tests PN: P100001T) and a diluent kit. Refer to the AimPlex Multiplex Immunoassay User Manual and kit inserts for the assay procedure.
Storage: 2-8 C in the dark.
Important: Sodium azide forms explosive compounds with heavy metals. These products contain <0.05% (w/w) azide which with repeated contact with lead and copper commonly found in plumbing drains may result in the buildup of shock sensitive compounds. Dispose in accordance with regulations from your institute.
For Research Use Only. Not for use in diagnostic procedures.
Sample types: Cell culture supernatant, serum, plasma, bodily fluid and tissue/cell lysate
Sensitivity (LOD): < 5 pg/mL
LLOQ: < 10 pg/mL
ULOQ: > 5,000 pg/mL
Standard dose recovery: 70-130%
Intra-assay CV: < 10%
Inter-assay CV: < 20%
Cross-reactivity of analytes in Human Group 2: Negligible
Sample volume: 15 µL/test
Interleukin 11 (Accession P20809) is a member of the IL-6 cytokine family. IL-11 activity has been observed in hematopoietic cells, the tissues of the central nervous system, and in the gastrointestinal organs. In concert with IL-11Rα, IL-11 is believed to activate downstream signaling pathways for the regulation of platelet maturation, adipogenesis, neurogenesis, and osteoclastogenesis, as well as placentation. IL-11 can increase the tumorigenic ability of cells. As over expression is associated with many types of cancer, inhibiting its signaling pathway may be effective in treating cancer. Recombinant IL-11 is currently on the market for cancer patients to prevent extreme thrombocytopenia.
Girasole G, Passeri G, Jilka RL, Manolagas SC. Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest. 1994; 93(4) 1516-1524. Doi: 10.1172/JCI117130.
Putoczki TL, Ernst M. IL-11 signaling as a therapeutic target for cancer. Immunotherapy. 2015; 7(4): 441-53. Doi: 10.221/imt.15.17.
Sitaraman SV, Gewirtz AT. Oprelvekin. Genetics Institute. Curr Opin Investig Drugs. 2001. 2(10): 1395-400. PMID: 11890354.
Xu DH, Zhu Z, Wakefield MR, Xiao H, Bai Q, Fang Y. The role of IL-11 in immunity and cancer. Cancer Lett. 2016; 373(2): 156-63. Doi: 10.1016/j.canlet.2016.01.004.